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Autism spectrum disorders (ASDs) are a complex neurodevelopmental disorder that display
a triad of core behavioral deﬁcits including restricted interests, often accompanied by
repetitive behavior, deﬁcits in language and communication, and an inability to engage
in reciprocal social interactions. ASD is among the most heritable disorders but is not a
simple disorder with a singular pathology and has a rather complex etiology. It is interesting
to note that perturbations in synaptic growth, development, and stability underlie a variety
of neuropsychiatric disorders, including ASD, schizophrenia, epilepsy, and intellectual
disability. Biological characterization of an increasing repertoire of synaptic mutants in
various model organisms indicates synaptic dysfunction as causal in the pathophysiology
of ASD. Our understanding of the genes and genetic pathways that contribute toward the
formation, stabilization, and maintenance of functional synapses coupled with an in-depth
phenotypic analysis of the cellular and behavioral characteristics is therefore essential to
unraveling the pathogenesis of these disorders. In this review, we discuss the genetic
aspects of ASD emphasizing on the well conserved set of genes and genetic pathways
implicated in this disorder, many ofwhich contribute to synapse assembly andmaintenance
across species.We also reviewhow fundamental research using animalmodels is providing
key insights into the various facets of human ASD.
Keywords: autism spectrum disorder, synapse, animal models, genetics, epigenetics, environment, cell adhesion
molecules, scaffolding proteins
INTRODUCTION
Autism spectrum disorders (ASDs) are a complex set of het-
erogeneous neurodevelopmental disorders categorized by a triad
of key behavioral anomalies. Characteristic behavioral abnor-
malities consist of restricted interests accompanied by repetitive
behavior, deﬁcits in language and communication, and the inabil-
ity to engage in reciprocal social interactions (Abrahams and
Geschwind, 2008; Betancur et al., 2009; Levitt andCampbell, 2009;
Peca et al., 2011b; Zoghbi and Bear, 2012). Autism is not a singu-
lar disease entity. The disorder encompasses a spectrum of wide
ranging phenotypic manifestations which span from debilitating
impairments to mild behavioral and personality traits. Therefore,
autism is rightfully referred to as “autism spectrum disorders”
(Persico and Bourgeron, 2006).
Autism spectrum disorder appears to be involved in early
brain development. Obvious signs and symptoms show early
onset within the ﬁrst 3 years of life and persist into adult-
hood. According to the recent reports from the Center for
Disease Control, an estimated 1 in 88 children has been identi-
ﬁed with ASD. Interestingly, these disorders show a gender bias
where males are affected almost ﬁve times more than females
(http://www.cdc.gov/Features/CountingAutism/). ASD is among
the most heritable disorders evidenced by family and twin stud-
ies with a concordance rate of 70–90% for monozygotic twins
(Folstein and Rutter, 1977; Steffenburg et al., 1989; Bailey et al.,
1995; Folstein and Rosen-Sheidley, 2001). Nevertheless, heri-
tability in this case is more complex due to the differences in
manifestations of its core symptoms, gradual changes over time,
and differing degrees of response to interventions (Abrahams and
Geschwind, 2008; Levitt and Campbell, 2009). 10–25% of ASD
cases seem to have an underlying genetic disorder such as fragile X
syndrome, tuberous sclerosis (TSC), andRett syndrome (Betancur
et al., 2009).
Recent studies have highlighted numerous potential risk fac-
tors that may contribute to ASD. These risk factors range from
genetic, to epigenetic, to environmental factors. Detection of copy
number variations (CNV), point mutations, and identiﬁcation of
rare variants in synaptic cell adhesion proteins and pathways are
some of the ways researchers are providing insight into the patho-
physiology of ASD (Sebat et al., 2007; Malhotra and Sebat, 2012;
Zoghbi and Bear, 2012). It is worthwhile to note that the genes and
the genetic pathways implicated in ASD, and the identiﬁcation of
any causal rare variants are accessible to modeling in experimen-
tal systems. Research ﬁndings both from studying human genetics
and animal models of ASD suggest that disruption of synapse
formation and stabilization processes is a key underlying feature
in ASD etiology. Dysfunctions in the assembly or structure of
transmembrane and scaffolding proteins needed for building and
maintaining synapses, and disruption in cellular signaling path-
ways controlling synaptogenesis are major contributing factors in
ASD.
A large portion of this reviewwill emphasize thewell-conserved
sets of genes and genetic pathways implicated in ASD, many of
which contribute to synapse assembly and maintenance across
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different species. Given the complexity and heterogeneity of this
disorder, it has proved challenging tounravel the underlying causes
of ASD from human clinical population alone. Nevertheless,
numerous animalmodels have been utilized that have enormously
contributed toward understanding speciﬁc aspects that constitute
the spectrum of these disorders.
HISTORICAL OVERVIEW OF AUTISM SPECTRUM DISORDERS
Leo Kanner, a psychiatrist, initially described autism well over
half a century ago (Kanner, 1943, 1968, 1971). Studies on the
relationship between autism and abnormal electroencephalogram
were among the ﬁrst to suggest autism as a disorder of brain
function (Creak and Pampiglione, 1969). Despite these ground-
breaking observations on autism, early identiﬁcation of autism
was marred by lack of adequate diagnostic criteria. It was not
until the introduction of the concept of “autism triad” that high-
lighted the now well-established characteristics of impairment
in social interaction, language and communication did Autism
become a recognizable disorder. Since then the clinical concep-
tualizations of ASD have consistently evolved together with a
steady rise in the number of ASD cases. Our current under-
standing of ASD is that of a complex neurological disorder that
continues to challenge our ability to identify the underlying causal
mechanisms.
MANY FACETS OF AUTISM SPECTRUM DISORDERS
GENETICS – COPY NUMBER VARIATION
Copy number variation is among the most widespread of struc-
tural variations in the human genome, and is increasingly being
implicated as a major contributor to the pathophysiology of
complex neurodevelopmental disorders (Sebat et al., 2007, 2009;
Christian et al., 2008; Kumar et al., 2008; Marshall et al., 2008;
Weiss et al., 2008; Bucan et al., 2009; Glessner et al., 2009;Merikan-
gas et al., 2009; Luo et al., 2012; Malhotra and Sebat, 2012).
CNVs largely comprise of duplications and deletions and can
be de novo or familial. De novo CNVs are more prevalent in
causing sporadic genomic disorders (McCarroll et al., 2008). The
duplication or deletion events disrupt gene structure, expres-
sion, and function and are a common cause of developmental
delay. Several studies suggest important role of CNVs in disease
etiology, susceptibility, and inheritance (Beckmann et al., 2007;
Estivill and Armengol, 2007). Large-scale genome-wide associ-
ation studies are credited for detection of CNVs in rare cases
of ASD (Ma et al., 2009a). Duplications and microdeletions in
many loci are associated with ASD. Several studies identiﬁed
duplication CNVs within 15q13 (Christian et al., 2008; Miller
et al., 2009) and microdeletions at many loci in 16p11.2 (Sebat
et al., 2007; Marshall et al., 2008; Weiss et al., 2008; Levy et al.,
2011; Sanders et al., 2011), Williams syndrome locus 7q11.23,
DiGeorge syndrome locus 22q11.2, 1q21.1, and Prader–Willi
and Angelman syndromes at 15q11-13 (Glessner et al., 2009;
Sanders et al., 2011).
Interestingly, genes associated with CNVs in ASD are involved
in regulating synaptogenesis. Some of the genes include NEU-
ROLIGIN 4 (NLGN4; Jamain et al., 2003; Laumonnier et al., 2004),
SHANK3 (Durand et al., 2007; Moessner et al., 2007; Gauthier
et al., 2009), TBX1, PCDH10, and NHE9 (Morrow et al., 2008).
Recent ﬁndings further reiterate a correlation between synapse
formation and autism (Glessner et al., 2009; Mitne-Neto et al.,
2011). In addition to these genes, some of the other genes rec-
ognized as risk factors in ASD include NEUREXIN 1 (NRXN1;
Kim et al., 2008; Bucan et al., 2009), SHANK2 (Berkel et al., 2010),
CNTN4 (Fernandez et al., 2004), CNTNAP2 (Bakkaloglu et al.,
2008; Penagarikano et al., 2011),DPYD andDPP6 (Marshall et al.,
2008); NLG1 (Glessner et al., 2009) and SYNGAP1, DLGAP2
(Pinto et al., 2010). A detailed list of genes, their potential func-
tions and genetic pathways linked to ASD are summarized in
Table 1.
EPIGENETICS
Epigenetic mechanisms underlie several human neurodevelop-
mental disorders. Genomic imprinting, epimutations, DNA
methylation, and histone modiﬁcations are all examples of epige-
netic mechanisms linked to the development of certain disorders.
These mechanisms involve modiﬁcations of nucleotides or chro-
mosomes without altering the genetic sequence (Zoghbi, 2003;
Egger et al., 2004). Thus causing modiﬁcations in gene expression
that may increase the likelihood of developing a particular disease.
Epigenetic mechanisms are believed to function at the interface
between genetic and environmental factors (Jiang et al., 2004; Qiu,
2006). Studies linking these two factors are gaining importance for
understanding the etiologies of complex disorders and could play
a role in the development of ASD.
While epigenetic mechanisms are implicated in the develop-
ment of many disorders, they are also an intrinsic phenomenon
for normal brain development. Genomic imprinting is an example
of an epigenetic mechanism that occurs normally throughout life.
This is when one of the two parental alleles for an imprinted gene
becomes inactive due to DNA methylation resulting in monoal-
lelic gene expression. This phenomenon occurs quite frequently
in humans but was also discovered in fungi, plants, and other
animals (Martienssen and Colot, 2001; Jiang and Kohler, 2012).
Using genome-wide scans, several areas on chromosomes known
as, hot spots for genomic imprinting, were located on loci 7q and
15q (Reik andWalter, 2001; Luedi et al., 2007). Interestingly, these
loci are highly affected in individuals with ASD (International
MolecularGenetic Study of AutismConsortium,2001; Lamb et al.,
2005). Several studies have linked duplication or deletion events
on the active chromosome toASD (Cook et al., 1997; Schroer et al.,
1998; Koochek et al., 2006). Individuals with Angelman syndrome
(Mabb et al., 2011; Huang et al., 2012) and Prader–Willi syndrome
(Miyake et al., 2012) show a defect in the active allele that leads
to loss of gene expression. Such correlations provide compelling
evidence for the role of genetic and epigenetic mechanisms in the
etiology of ASD.
Additionally, DNA methylation is an important basic step in
epigenetic gene control. Methyl-CpG binding proteins bind to the
methylated DNA regions to control gene expression. Mutations
in methyl-CpG binding protein 2 (MeCP2) cause Rett syndrome
which shows characteristic autistic-like behavior in addition to
seizures, ataxia, and stereotypic hand movements (Amir et al.,
1999). More recently, MeCP2 was shown to regulate several genes
involved in synaptic plasticity, neuronal cell proliferation and neu-
ronal transcription factors including: brain-derived neurotrophic
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Table 1 | Conserved genes implicated in ASD.
Gene Protein description Nature of abnormality Reference
NRXN1 Transmembrane Mutation, CNVs Feng et al. (2006)
NRXN2 Transmembrane Mutation Arstikaitis et al. (2011)
NRXN3 Transmembrane Mutation Vaags et al. (2012)
NLGN1 Transmembrane Genetic association Glessner et al. (2009)
NLGN3 Transmembrane Mutation Jamain et al. (2003)
NLGN4 Transmembrane Mutation, CNVs Jamain et al. (2003)
CNTN3 Ig-CAM Mutation, CNVs Morrow et al. (2008)
CNTN 4 Ig-CAM Mutation Roohi et al. (2009)
CNTNAP2 Transmembrane Mutation, genetic association Arking et al. (2008)
NrCAM Ig-CAM Genetic association Marui et al. (2009)
CDH9/10 Transmembrane Genetic association Bucan et al. (2009)
CDH18 Transmembrane Chromosomal abnormality Marshall et al. (2008)
PCDH9 Transmembrane Mutation Marshall et al. (2008)
PCDH10 Transmembrane Mutation Morrow et al. (2008)
PCDH19 Transmembrane Mutation Dibbens et al. (2008)
SHANK1 Scaffolding Mutation Sato et al. (2012)
SHANK2 Scaffolding Mutation Berkel et al. (2010)
SHANK3 Scaffolding Mutation Durand et al. (2007)
DLG4 (disk large homolog 4) Scaffolding SNPs Feyder et al. (2010)
HOMER1 Scaffolding Mutation Kelleher et al. (2012)
cAMP-GEF (guanine exchange factor) Cytoskeletal Mutation Bacchelli et al. (2003)
RELN (Reelin) Secreted Genetic association Persico et al. (2001)
EN2 (Engrailed 2) Transcription factor Genetic association Gharani et al. (2004)
factor (BDNF), distal-less homeobox 5 (DlX5), and insulin-like
growth factor binding protein 3 (IGF3; Chen et al., 2003; Mar-
tinowich et al., 2003; reviewed in Miyake et al., 2012). Thus,
epigenetic misregulation of synaptic genes could potentially con-
tribute to ASD (Beaudet, 2007). Yet another set of studies suggest
that extrinsic factors like the environment can alter epigenetic
make up leading to defective neuronal functions (Jessberger et al.,
2007; Ma et al., 2009b).
ENVIRONMENT AND OTHER FACTORS
Environmental contributions and other modulating factors are
emerging as potential risk factors for ASD. Heavy metals, parental
age, immunological proteins, environmental pesticides and insec-
ticides, and food contaminants are thought to act asmodulators of
ASD (Durkin et al., 2008). These factors could contribute toward
an increase in the prevalence of ASD but may not be sufﬁcient to
cause ASD. Nonetheless, a major challenge is to identify environ-
mental factors relevant to ASD that could inﬂuence susceptibility,
severity, and intervention outcomes. Heritable genetic vulnerabil-
ities can magnify the adverse effects triggered by environmental
factors. If both genes and environment converge, a resulting
dysfunction of neurotransmitters and signaling pathways could
take place at key developmental time points (Pessah et al., 2008).
The toxicological literature point toward several environmental
chemicals of concern to human health that can either directly or
indirectly affect signaling pathways impaired in ASD.
Prenatal exposure to certain pesticides and insecticides are
known to inhibit acetylcholine (ACh) and γ-aminobutyric acid
(GABA; Shelton et al., 2012). Studies show these neurotransmitter
systems are altered in a subset of autistic individuals. Similarly,
environmentally induced alterations in calcium signaling path-
ways caused by organic pollutants, impact a broad range of
neurotransmitter systems like the cholinergic, GABAergic, and
dopaminergic systems (Pessah et al., 2008; Corrales and Herbert,
2011). In addition to disruptions in important neuronal signaling
pathways, pesticides can cause oxidative stress, neuroinﬂamma-
tion, and mitochondrial dysfunction, all contributors to neuronal
cell-death and dysfunction (Herbert, 2010; Shelton et al., 2012).
Furthermore, cytokine-mediated inﬂuences and immune-related
proteins are also listed as modulating factors for ASD (Ashwood
et al., 2011; Onore et al., 2012). Families with ASD often show
clustering of autoimmune disorders (Croen et al., 2005; Currenti,
2010). Several reports indicate the presence of serum antibody
reactivity against human cortical and cerebellar regions of the
brain in autistic patients (Silva et al., 2004). This process is thought
to begin in utero and is associated with placental transfer of mater-
nal autoantibodies to neuronal proteins potentially leading to
neuronal dysfunction.
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ANIMAL MODELS OF AUTISM SPECTRUM DISORDERS
Autism spectrum disorder is a complex disorder with no singu-
lar pathology and because of this a collective and collaborative
approach is the key to understanding its etiology and design of
rational interventions. Studies in animals are aimed at modeling
the core phenotypes associated with ASD, including communi-
cation and social impairments, restricted interests, and repetitive
behaviors in an attempt to uncover the mechanisms that under-
score the entire spectrum of the disorder. In this section, we will
uncover the wide range of both invertebrate and vertebrate model
systems utilized by researchers that have collectively made signif-
icant contributions toward understanding the mechanisms that
underlie ASD (summarized in Table 3).
NON-HUMAN PRIMATES
One of the animal models largely believed to help bridge the gap
between humans and lower vertebrate systems is the non-human
primate (NHP) model. NHP model is relevant for understanding
ASD due to its high degree of correspondence to human behav-
ior and their striking homology in the anatomy of neural circuits
that mediate social behavior (for review, see Ongur and Price,
2000; Watson and Platt, 2012). Some of the behavioral corre-
lates that NHPs have with human behavioral deﬁcits seen in ASD
include repetitive behaviors (Lutz et al., 2003; Alarcon et al., 2008),
social communication (Ghazanfar and Santos, 2004), and their
ability to follow other’s gazes, a tendency that is compromised
in Autism. For example, ablation studies in NHPs especially of
the superior temporal sulcus region reveal difﬁculties in respond-
ing to social cues like eye gaze (Campbell et al., 1990). The lesion
model involving the amygdala in NHPs is used to study alter-
ations in socio-emotional behaviors (Amaral et al., 2003). Some
papers speculate on the involvement of mirror neurons in the
development of ASD (Oberman et al., 2005). In early childhood
development, mirror neurons may play a key role in mimicking
behaviors, actions, and language. A failure in the development
or proper organization of mirror neurons might be linked to
some of the behavioral phenotypes associated withASD (Williams
et al., 2001). NHP, like humans, possess mirror neurons and
their use as a model system could provide some insight into
the involvement of mirror neurons in ASD. NHP models are
also used to investigate immunological factors in the etiology of
ASD.Autoantibodies present in children withASD have prompted
investigators to analyze the affects of maternal IgG antibodies
on the fetal brain during gestation. Injections of IgG antibod-
ies from human mothers who had multiple children with ASD to
pregnant rhesusmonkeys resulted in abnormal stereotyped behav-
iors in offspring, and increased activity of offspring compared
to controls (Martin et al., 2008). Although use of NHP model
has the capability of contributing to some of the more behav-
ioral aspects of ASD research, the absence of genetic knockouts
in NHPs modeling ASD together with the careful considerations
of ethical implications of NHP research tend to pose limitations
that can be better addressed using rodents and invertebrate model
systems.
RODENTS
Mouse models recapitulating symptoms of ASD through selective
manipulations of genes and neural circuitry is a much more
amenable model system compared to NHP models. Currently,
there is a sizeable number of autismmouse models available made
possible due to generation of speciﬁc gene knockouts; mutations
in these genes are thought to contribute to ASD together with
the emergence of CNVs and high-end genome-wide sequenc-
ing studies. Mouse models of human disorders have limitations
in recapitulating the entire phenotypic spectrum (Arguello and
Gogos, 2006). The validity of mouse models of human disorders
are based on three criteria: (i) construct validity as provided by
knock outs that carry a mutation in a gene that is affected in the
human disorder (Peca et al., 2011a), (ii) face validity as reﬂected
in animals that bear many of the core and ancillary physical or
behavioral resemblances to the human disorder (Crawley, 2004),
and (iii) predictive validity, which by far, is themost challenging to
accomplish and indicates a similar response in the mouse model
to an intervention that is known to be effective in human patients
with that disorder.
Some of the mouse models representing syndromic forms
of ASD include mice modeling Phelan–McDermid syndrome
(SHANK3; Bangash et al., 2011; Peca et al., 2011a), Rett syndrome
(MeCP2; Shahbazian et al., 2002; Moretti et al., 2006), fragile X
syndrome (FMR1; Ronesi et al., 2012), Timothy syndrome (TS;
CACNA1C; Bader et al., 2011), and others (see also Table 2). Neu-
roligin 3 knock out mice serve as a model for non-syndromic
Table 2 | Genetic syndromes with ASD-related phenotypes.
Syndrome Chromosome Genes Reference
Angelman 15q11 Ube3A Nurmi et al. (2001)
Phelan–McDermid 22q13 Shank3 Durand et al. (2007)
Rett Xq28 MeCP2 Amir et al. (1999)
Tuberous sclerosis 9q34 TSC1 Baker et al. (1998), Smalley (1998)
16p13 TSC2
Timothy 16p13 CACNA1C Splawski et al. (2004)
Fragile X Xq27 FMR1 Rogers et al. (2001)
Cortical dysplasia-focal epilepsy syndrome 7q35 CNTNAP2 Arking et al. (2008)
Smith–Lemli–Opitz 11q13 DHCR7 Tierney et al. (2001)
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Table 3 | Phenotypic analyses and relevant animal models of ASD.
Phenotype Animal models
Non-human primate Mouse Rat Prairie vole Songbird Zebrafish Drosophila Aplysia C. elegans
Genetic analyses + + + + + +
Molecular analyses + + + + + + +
Hyperactivity and repetitive behavior + + +
Social communication + + + + +
Cognition + +
Impaired vocalization + +
autism (Baudouin et al., 2012). Other examples of mouse models
to study characteristics of ASD includePurkinje-speciﬁc knockout
of TSC1 (Tsai et al., 2012), chromosome-engineeredmousemodel
for human 15q11-13 (Nakatani et al., 2009), model for 16p11.2
lesion found in autism (Horev et al., 2011), 22q11.2 mice lacking
PTEN (Zhou et al., 2009), CNTNAP2 (Penagarikano et al., 2011),
SHANK2 (Won et al., 2012), and SCN1A (Han et al., 2012). The
impressive array of mouse models displaying behaviors that are
reﬂective of the human behavioral and cognitiveASD symptoms is
highly informative. On the other hand, the behavioral phenotypes
between mouse models with ablation of the same gene show vari-
ations based on either their genetic backgrounds (Crabbe et al.,
1999), or how individual laboratories conduct their behavioral
assays further underscoring the impact of the genetic background
or the local environment on the displayed phenotypes. In any case,
a complete understanding of the similarities and differences in the
behavioral phenotypes across the ASD mouse models will pro-
vide key insights into the underlying neural circuitry behind these
behaviors.
Other emerging rodent models of ASD include rat and prairie
vole (McGraw and Young, 2010). Rats that are injected with val-
proic acid (VPA) serve as an environmentally triggered model of
autism and this method has emerged as a new way to study ASD
in rats (Rodier et al., 1997). VPA injected to gestational mothers
before neural tube closure causes autistic-like phenotypes in off-
spring such as a reduction in the number of cerebellar Purkinje
cells and disruption in inhibitory circuits (Gogolla et al., 2009).
Furthermore, these animals show similar behavioral phenotypes
Table 4 | Receptors, transporters, and channel proteins in ASD.
Gene Gene name Genetic abnormality Reference
AGTR2 Angiotensin II receptor, type 2 Mutation Vervoort et al. (2002)
ADRB2 Adrenergic β-2 receptor Genetic association Cheslack-Postava et al. (2007)
AVPR1A Arginine vasopressin receptor 1A Mutation, genetic association Yirmiya et al. (2006)
DRD3 Dopamine receptor D3 Genetic association de Krom et al. (2009)
ESRRB Estrogen-related receptor β Genetic association Wang et al. (2009)
GABRB3 GABA A receptor, β3 Genetic association Cook et al. (1998)
GABR4/GABRB1 GABA A receptor, α4/β1 Genetic association Ma et al. (2005)
GRIP1 Glutamate receptor interacting protein Mutation, genetic association Mejias et al. (2011)
GRIK2 Glutamate receptor, kainate 2 Genetic association Jamain et al. (2002)
GRIN2A Glutamate receptor, ionotropic, N -methyl D-aspartate 2A Mutation Barnby et al. (2005)
GRIN2B Glutamate recepto14r, ionotropic, N -methyl D-aspartate 2B Mutation O’Roak et al. (2011)
GRID1 Glutamate receptor, δ1 Mutation Glessner et al. (2009)
GRID2 Glutamate receptor, δ2 Mutation Schaaf et al. (2011)
GRM5 Glutamate receptor metabotropic 5 Mutation Iossifov et al. (2012)
OXTR Oxytocin receptor Genetic association Wu et al. (2005)
SL6A4 Solute carrier family 6 (serotonin transporter) Genetic association Sutcliffe et al. (2005)
SLC25A13 Solute carrier family 25 (aspartate-glutamate carrier) Genetic association Ramoz et al. (2004)
CACNA1C Calcium channel, α1B subunit Mutation Splawski et al. (2004)
SCN1A/SCN2A Sodium channel, α subunit Mutation Weiss et al. (2003)
KCNJ10 Potassium channel subfamily Genetic association Sicca et al. (2011)
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associated with autism including lower sensitivity to pain and
higher sensitivity to non-painful stimuli, repetitive behaviors,
hyperactivity, and decreased number of social behaviors. They
also show delayed mental impairments and lower body weight
(Schneider and Przewlocki, 2005; Favre et al., 2013). Prairie voles
also generated interest in the area of ASD because of their ability to
form lasting social bonds and their nurturing behavior. Impaired
social behaviors and deﬁcits in various aspects of social cognition
are some of the signature of ASD in humans. Thus, development
of genetic, molecular, and genomic tools in prairie vole will likely
be useful in basic and translational research that may be relevant
to ASD (McGraw and Young, 2010).
ZEBRAFISH
Zebraﬁsh are widely used as a model for studying vertebrate
development and although not as popular as the mouse model
for studying ASD, zebraﬁsh are being used to dissect the genetic
basis of autism due to a multitude of genetic techniques avail-
able. These include lineage tracing using ﬂuorescent tracers or
labeling cells with lipophilic dyes, loss of function analyses using
chemicals, transposable elements, and gain of function assays
such as those involving microinjection of synthetic mRNA. In
addition, morpholino technology is widely used as an efﬁcient
reverse genetic approach to understand gene function (Tropepe
and Sive, 2003). Furthermore, fast oogenesis and embryogene-
sis, and high fecundity allows for rapid experimental assays in this
model. Transparency and external development of embryos allows
for the study of growth and development of cells and tissues in live
embryos (Tropepe and Sive, 2003). Additionally, zebraﬁsh are an
excellent model for use in carrying out genetic screens to identify
new genes of interest and are useful in designing genetic screens to
uncover speciﬁc enhancers or suppressors of particular phenotype
(Dooley and Zon, 2000). These screens identiﬁed several candi-
date genes, such as Reelin and MET that confers susceptibility to
human ASD in zebraﬁsh (Rice and Curran, 2001). The presence
of structurally and functionally homologous regions in zebraﬁsh
brain, which are perturbed in human autistic patients, is another
avenue that zebraﬁsh researchers are taking advantage of to study
brain development and neuronal connections. Although zebraﬁsh
is an excellent model to study some of the genetic aspects of ASD,
the behavioral phenotypes associated with ASD are difﬁcult to
recapitulate (Tropepe and Sive, 2003). Thus, other model systems
might be useful in studying some of the behavioral phenotypes
associated with ASD.
SONGBIRDS
Songbirds can be used both as a molecular and a behavioral
model for understanding the etiology of ASD. Songbirds are
socially sophisticated and display characteristically human traits
like monogamy and cultural inheritance while demonstrating the
ability to learn vocalizations (Clayton et al., 2009). Vocal learning
is an important element of language. Impairments in vocal and
language learning are some of the core deﬁcits in autism. Thus,
understanding vocal learning through songbirds has emerged as
an important model to study some aspects of ASD.
Speech in humans and bird songs display striking parallels in
that both seem to have a critical developmental time window for
learning, a homologous underlying neural circuitry involving a
loop between the cerebral cortex, basal ganglia, and thalamus,
and a role for social inﬂuences in the learning of vocalizations
(Panaitof, 2012). Studies from songbird indicate that CNTNAP2,
which is implicated in human ASD and is enriched in human lan-
guage related neural circuits (Alarcon et al., 2008), might play a
role in vocal communication in songbirds as well (Panaitof et al.,
2010). Similar to developinghumanbrainwhereCNTNAP2 shows
a gradient distribution in frontal cortical areas, Cntnap2 expres-
sion is either enhanced or reduced in key song control nuclei
in songbird brain. In the absence of an animal model that can
address language deﬁcits, songbird model may prove useful for
further exploration of the cellular and molecular mechanisms
underlying the homologous neural circuitry that underscore lan-
guage development in humans. Recently, using microarray and
in situ hybridization analyses, large databases have been compiled
that reveal expression patterns of certain genes in speciﬁc regions
of the brain (Warren et al., 2010). Expansion on the molecular
aspects of these observations has further increased the validity of
behavioral songbird research. While linking behavior and genet-
ics in songbirds is a tall order, it might still provide important
clues about neuronal circuitry and language acquisition in the
complex and heterogeneous nature of ASD and its behavioral
manifestations.
INVERTEBRATE MODELS
Despite being millions of years apart on the evolutionary scale
there is a surprising degree of genetic conservation between inver-
tebrates and humans. Invertebrate models have made seminal
contributions toward a basic understanding of human neurologi-
cal disorders that are hard to ignore. One such classic invertebrate
model for studying human neurodevelopmental disorders is the
fruit ﬂy, Drosophila. The fruit ﬂy has proven to be an impor-
tant model time and again to study various disorders where a
single, causative genetic defect has been identiﬁed in Rett syn-
drome (Cukier et al., 2008), fragile X syndrome (Morales et al.,
2002), and Angelman syndrome (Wu et al., 2008; see also Table 2).
Drosophila studies have advanced our fundamental understanding
of some of these human disease gene functions, which show fea-
tures of ASD. Recent studies in Drosophila have started to unravel
some of the key genes, such as Neurexin 1 (Li et al., 2007; Zeng
et al., 2007), Neuroligin 1 (Banovic et al., 2010), and Neuroli-
gin 2 (Chen et al., 2012), which are the ﬂy homologs of human
NRXNs and NLGNs, respectively, that are implicated in ASD (De
Jaco et al., 2005; Sudhof, 2008). With the unmatched power of
Drosophila genetics and the potential of carrying out large scale
screens using the sophisticated genetic tools available, Drosophila
will undoubtedly continue to provide key mechanistic insights to
dissect the genetic basis of ASD and likely facilitate the design
of therapeutics. Apart from Drosophila, other invertebrate mod-
els that are being used to study aspects of ASD are C. elegans
(Calahorro and Ruiz-Rubio, 2011, 2012) and Aplysia (Choi et al.,
2011; Ye and Carew, 2011).
A recent study inAplysia showed that trans-synaptic Neurexin–
Neuroligin interactions govern synaptic remodeling and regulates
signaling required for the storage of long-term memory, includ-
ing emotional memory, an ability that is affected in ASD patients
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(Choi et al., 2011). This study showed that long-term facilita-
tion and associated pre-synaptic growth were compromised when
neurexin or neuroligin was depleted from pre- and post-synaptic
machineries. In addition, an introduction of R451C mutation of
NLGN3 associated with human ASD blocked both intermediate-
and long-term facilitation in Aplysia (Choi et al., 2011).
Another genetically tractable animal model is the nematode,
C. elegans, which are utilized to understand the underlyingmecha-
nisms and abnormalities in neuronal synaptic communications in
complex human neurological disorders like Alzheimer’s and ASD
(Calahorro and Ruiz-Rubio, 2012). C. elegans have orthologs for
ASD-related genes such as NLGNs, NRXNs, and SHANK. Recent
reports highlight behavioral phenotypes in C. elegans reminiscent
of ASD following removal of neuroligin homolog, nlg-1 (Hunter
et al., 2010; Calahorro and Ruiz-Rubio, 2012) and subsequent
functional phenotypic rescue by human NLGN1 (Calahorro and
Ruiz-Rubio, 2012). Additionally, trans-synaptic NRX-1 and NLG-
1 inC. elegans are found tomediate retrograde synaptic inhibition
of neurotransmitter release at the neuromuscular junction (Hu
et al., 2012) further underscoring the function of these molecules
in synaptic modulation.
Thus determining the biological underpinnings of ASD will
require a concerted effort involving studies from human clinical
populations and several different animal models. This effort will
provide complementary and critical insights toward understand-
ing the complex and unknown ASD etiology. Since testing the
causality and exploring the molecular and cellular mechanisms
of ASD are either severely limited or off limits in human popu-
lations, research using various animal models will provide clues
to the range of functional deﬁcits that cause the disorder and may
even hint at the underlying neural circuits that drive the behavioral
deﬁcits.
GENES IMPLICATED IN ASD
With the growing repertoire of synaptic genes implicated in ASD,
it is becoming increasingly clear that synaptic dysfunction at mul-
tiple levels may underlie ASD. Synapses comprise of pre- and
post-synaptic elements (Figure 1; see also review by Delorme
et al., 2013) like synaptic cell adhesion molecules (CAMs), ion
channels, neurotransmitter receptors, scaffolding and cytoskeletal
proteins that work harmoniously to provide synaptic structural
integrity and functionality (refer Tables 1 and 4). Perturbations
in synaptic assembly or function are commonly reported in many
neuropsychiatric disorders (Blanpied and Ehlers, 2004).
CELL ADHESION MOLECULES
Neuroligins
Neuroligins (NLGNs) are post-synaptic CAMs localized at gluta-
matergic or GABAergic synapses (Song et al., 1999; Varoqueaux
et al., 2004). NLGNs have a large extracellular cholinesterase-
like domain, and a small intracellular domain with PDZ-binding
motif. There are ﬁve NLGNs, which include two X-linked genes
(NlgN3 and NlgN4X) and one Y-linked (NlgN4Y ). The identi-
ﬁcation of ASD-linked mutations in NLGN3 and NLGN4X was
an important ﬁnding that implicated these genes in the etiol-
ogy of ASD (Jamain et al., 2003) and linked ASD to molecules
with synaptic function. In vitro studies using mutant forms
of NlgN3 and NlgN4X showed retention of the mutant pro-
teins in endoplasmic reticulum resulting in reduced cell surface
binding to Neurexin (NRXN; Chih et al., 2004; Comoletti et al.,
2004; Boucard et al., 2005). Some of the mutations of NLGNs
seen in ASD patients were generated in mice and other model
systems. For example, NlgN3 R451C knock-in mice showed
challenged social interactions, enhanced inhibitory synaptic trans-
mission, and altered spatial learning abilities (Jamain et al., 2003;
Tabuchi et al., 2007; Chadman et al., 2008). This arginine to cys-
teine point mutation at the analogous position as the human
NLGN3 R451C was recently made in Aplysia revealing abnor-
mal synaptic facilitation (Choi et al., 2011). NLGN3 knock out
mice showed reduced ultrasound vocalization together and a lack
of social novelty preference (Radyushkin et al., 2009). NlgN4
knock out mice displayed reduced reciprocal social interac-
tions and vocalizations consistent with observations in human
ASD patients (Jamain et al., 2008). Studies on NlgN1 knock
out mice showed impaired NMDA receptor signaling, while
NlgN2 knock out mutants revealed reduced inhibitory synap-
tic transmission (Chubykin et al., 2007). Studies in vertebrate
and invertebrates alike have now established that NLGNs are
essential for proper synapse maturation, maintenance, and func-
tion as opposed to initial synapse formation (Chih et al., 2005;
Varoqueaux et al., 2006; Sudhof, 2008; Banovic et al., 2010; Chen
et al., 2012).
Recent studies on null mutants of Drosophila neuroligin 2
(dnlg2), which is the ﬂy homolog of human NlgN3 showed
reduced synaptic bouton numbers and synaptic transmission
(Chen et al., 2012). Interestingly, dnlg2 is required both pre-
and post-synaptically for proper synapse structure and func-
tion. Another study in C. elegans reported presence of Neuroligin
at both pre- and post-synaptic regions (Feinberg et al., 2008).
These studies highlight the exceptions to the traditional role and
localization of NLGNs at the post-synaptic terminals as seen
at most vertebrate synapses. It also raises interesting questions
about how synaptic organization might be ﬁne tuned, and how
signaling pathways might regulate the expression of pre- and
post-synaptic proteins during synaptic development and function.
Thus, studies on NLGNs using various model systems will pro-
vide key insights into how these synaptic CAMs are involved in
human ASD.
Neurexins
Neurexins (NRXNs) are predominantly presynaptic CAMs
(Ichtchenko et al., 1995), although they were also reported to
be expressed post-synaptically (Taniguchi et al., 2007). There are
threeNrxn genes,Nrxn1,Nrxn2, andNrxn3, each of which encode
α- and β-isoforms. The α-Neurexin extracellular domain con-
sists of six LNS domains interspersed by three EGF-like repeats
and interacts with various proteins in the synaptic cleft. Mouse
knock out mutants of individual Nrxns do not show gross abnor-
malities in synaptic ultrastructure or in synapse number while
triple α-Nrxn knock out mice die prenatally due to respiratory
complications. These mice show impaired synaptic transmission,
but not synapse formation suggesting that like their Nlgn lig-
ands, α-NRXNs are required for proper synaptic maintenance and
function, and not initial synapse formation (Missler et al., 2003).
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FIGURE 1 | Synaptic proteins implicated in neurodevelopmental and
neuropsychiatric disorders. A schematic illustration of an ensemble of pre-
and post-synaptic proteins. The majority of these proteins are highly
conserved across species, and thought to confer susceptibility to a host of
neurodevelopmental and neuropsychiatric disorders including ASD. The
cellular machinery of synapses is comprised of transmembrane heterophilic
(such as Neurexin and Neuroligin) and homophilic cell-adhesion molecules
(such as Cadherins and NCAM), cytoplasmic scaffolding proteins (such as
PSD-95, Cask, and Shank) and cytoskeletal proteins (such as Homer and
Cortactin) that link transmembrane and membrane-associated protein
complexes with the underlying actin cytoskeleton. One of the emerging
models in ASD is based on synaptic dysfunction in a molecular pathway that
is orchestrated by trans-synaptic Neurexin–Neuroligin-dependent proteins
complexes. This molecular assembly aligns the pre- and post-synaptic
apparatus facilitating functional activation and modulation of ion channels that
are in proximity to the neurotransmitter containing synaptic vesicles on the
pre-synaptic side. These protein complexes recruit other proteins both pre-
and post-synaptically and help organize functional neural networks. The
cytoskeletal scaffolding protein Cask is one such notable protein which binds
to the C-terminus of Neurexin. At the post-synaptic density, Neuroligin binds
to PSD-95, other molecules such as PSD-93, SAP97, and the SAPAP family of
proteins as well as the Shank family of scaffolding proteins help orchestrate
the post-synaptic area. Homer and Shank function is thought to stabilize the
post-synaptic density and serve as a platform to incorporate the post-synaptic
receptors (such as NMDAR, AMPAR, and mGluR) into the machinery. The
synaptic dysfunction in ASD may occur at multiple levels whereby failure to
organize proper protein–protein interactions at the synapse may compromise
neuronal functions (refer text for more details).
Pre-synaptic calcium channel function is also disrupted in α-Nrxn
knock outmice. Interestingly, compared to three NRXNs inmam-
mals,Drosophila has a single neurexin-1 (dnrx) gene which like its
vertebrate counterparts is pre-synaptic and is required for proper
synaptic growth and neurotransmission (Li et al., 2007).
NRXN1 has emerged as a strong candidate in ASD since the
identiﬁcation of overlapping de novo deletions in Nrxn1 in indi-
viduals with ASD. Although rare, missense mutations (Feng et al.,
2006; Kim et al., 2008) and deletions, and chromosomal aberra-
tions in the NRXN1 were also found in ASD patients (Marshall
et al., 2008; Zahir et al., 2008; Glessner et al., 2009). Interestingly,
NRXN1 deletions also confer risk for schizophrenia pointing to an
overlap between the two neurodevelopmental disorders (Betancur
et al., 2009; Rujescu et al., 2009).
Contactins
TheContactins (CNTNs) are glycosyl phosphatidyl-inositol (GPI)
anchored immunoglobulin (Ig) superfamily proteins with diverse
functions ranging from myelination (Berglund et al., 1999; Bhat
et al., 2001) to synapse formation and plasticity (Betancur et al.,
2009). Disruption of CNTN4 is associated with ASD (Fernandez
et al., 2004). Deletion and duplication in CNTN4 and small dele-
tions near CNTN3 have been identiﬁed in various patients with
ASD (Roohi et al., 2009). Since CNTN3 and CNTN4 expression
Frontiers in Cellular Neuroscience www.frontiersin.org February 2014 | Volume 8 | Article 58 | 8
Banerjee et al. Genetics of autism spectrum disorders
and localization overlaps with synaptogenesis in the developing
brain, it raises the possibility that mutations or genomic rear-
rangements in these genes seen in ASD could be attributed to
altered synapse formation and function.
Contactin-associated protein like 2
Contactin-associated protein like 2 (CNTNAP2) is a member of
Neurexin superfamily and is a locus that is signiﬁcantly asso-
ciated with susceptibility for ASD (Alarcon et al., 2008; Arking
et al., 2008). CNTNAP2 encodes CASPR2, a multidomain trans-
membrane protein that is best known for clustering potassium
channels at the juxtaparanodes in myelinated axons (Poliak et al.,
2003). CNTNAP2 localizes at high levels in human fetal brain
prior to myelination (Abrahams et al., 2007). It also shows a dis-
tribution gradient as frontal cortical enrichment in the developing
human brain, indicative of a role in patterning circuits that under-
lie higher cognition and language. Thus, CNTNAP2 might play a
role in the developing brain regions that are likely to be affected
in ASD. A recessive frameshift mutation in CNTNAP2 was identi-
ﬁed in individuals with cortical dysplasia focal epilepsy syndrome,
a congenital disorder, where majority of individuals displayed
characteristic features of ASD (Strauss et al., 2006). In addi-
tion, other studies that attribute CNTNAP2 to ASD include rare
single base pair mutations and common variations in the CNT-
NAP2 locus identiﬁed in patients with ASD (Alarcon et al., 2008;
Arking et al., 2008; Bakkaloglu et al., 2008; Falivelli et al., 2012).
Recent phenotypic characterization of Cntnap2 mutant mice
revealed deﬁcits in the three core ASD behavioral domains with
hyperactivity and epileptic seizures (Penagarikano et al., 2011).
These mutant mice also showed neuronal migration abnormal-
ities, a signiﬁcant reduction in the number of interneurons,
and abnormal neuronal network activity before the onset of
seizures. Most importantly, treatment with the FDA-approved
drug risperidone led to amelioration of the repetitive behav-
iors in the mutant mice further demonstrating a functional role
for CNTNAP2 in neuronal development and opening of new
avenues for therapeutic intervention in ASD (Penagarikano et al.,
2011).
NrCAM
NrCAM is a CAM that has gene homology to NgCAM and is
capable of homophilic cell adhesion as well as heterophilic inter-
actions with other non-NrCAM molecules such as Contactin-1,
Contactin-2/TAG1, and Neurofascin (Suter et al., 1995; Volkmer
et al., 1996; Pavlou et al., 2002). More recently, association analy-
sis has linked NrCAM to ASD (Sakurai et al., 2006). This study
showed over transmission of particular haplotypes of NrCAM
that modulate NrCAM expression in the brain, are associated
with a speciﬁc subset of autismwith a severe obsessive–compulsive
behavior. Several single nucleotide polymorphisms (SNPs) in the
NrCAM gene were also found to be associated with autism (Marui
et al., 2009) further underscoring NrCAM as a strong candidate
gene in ASD.
Cadherins
Cadherins (CDH) and protocadherins (PCDH) include a large
family of CAMs, a number of which are required for synap-
tic formation and function (Weiner et al., 2005; Arikkath and
Reichardt, 2008). CDHs mostly undergo homophilic cell adhe-
sion and are involved in intracellular signaling pathways associated
with neuropsychiatric disorders. Many of the CDHs have spe-
ciﬁc spatio-temporal expression patterns in the brain and loss of
CDHs leads to altered functional connectivity and neuronal infor-
mation processing in human brain (Redies et al., 2012). Recent
studies have identiﬁed de novo translocation deleting CDH18 in
ASD (Marshall et al., 2008). This study also reported CNVs associ-
atedwithPCDH9 gene inASD.Homozygous deletions inPCDH10
have also been shown in autistic children (Morrow et al., 2008).
Other CDHs and PCDHs are disrupted in disorders related to
mental retardation and intellectual disabilities (Weiner and Jontes,
2013).
ION CHANNELS
Ion channels are essential for regulating axonal conduction of elec-
trical activity and maintaining the optimum level of excitability
within the nervous system. Recent studies linked neuronal exci-
tation alterations with ASD pointing to a potential role for ion
channels in the etiology of ASD. Mutations in calcium, sodium,
and potassium ion channels seem to enhance neuronal excitability.
ASD-linked ion channel mutations involve the SCN1A (Nav1.1),
CACNA1C (Cav1.2), KCNMA1 (BK Ca2+), and KCNJ10 (Kir4.1)
channels (Ji et al., 2009; Liao and Soong, 2010; Li et al., 2011; Sicca
et al., 2011).
Nav1.1
SCN1A encodes the alpha subunit of the sodium channel type
1 (Nav1.1) which belongs to the voltage-gated sodium chan-
nel family necessary for axonal conduction and action potential
propagation. These transmembrane proteins possess a large pore-
forming alpha subunit and two auxiliary beta subunits. This
organization is important for allowing sodium ions to move
through the axonal membrane to initiate and propagate action
potentials. Recently, SCN1A has emerged as the most impor-
tant gene in epilepsy (Mulley et al., 2005). More that 70% of
individuals with epileptic encephalopathy posses a mutation in
the region encoding SCN1A causing severe myoclonic epilepsy
in infancy, also known as Dravet syndrome (DS; Harkin et al.,
2007). This disorder is often accompanied by certain behavioral
abnormalities such as hyperactivity, sleep-disorder, anxiety, atten-
tion deﬁcit, impaired social interactions, restricted interests, and
severe cognitive defects (Weiss et al., 2003; Ramoz et al., 2008;
O’Roak et al., 2012). Such behaviors are very similar to those
observed in patients with ASD and emerging evidence has linked
SCNA1 and ASD (Li et al., 2011). Researchers found that mice
with a loss of function mutation for SCN1A phenocopy DS and
show autistic-like behaviors (Han et al., 2012). It was suggested
that the autism-related traits in DS mice might be caused by a
decrease in inhibitory neurotransmission in GABAergic interneu-
rons due to SCN1A haploinsufﬁciency providing further evidence
that impairedGABAergic signalingmay underlieASD (Chao et al.,
2010).
Cav1.2
The calcium channels, voltage-dependent, L type, alpha 1C sub-
unit, also known as Cav1.2 encoded by the gene CACNA1C
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has been implicated in ASD. Cav1.2 channels are important in
the activation of transcription factors and play a key role in
promoting neuronal survival and dendritic arborization (Krey
and Dolmetsch, 2007). A mutation in the G406R region of the
CACNA1C gene is known to cause TS, a rare genetic disorder
that results in malformations of multi-organ systems, neurologi-
cal and developmental defects, and autism (Liao and Soong, 2010).
The mutation in this region causes prolonged inward current and
has dramatic effects on calcium channel inactivation (Splawski
et al., 2004). The cellular and molecular consequences of this
mutation are not yet known. Future studies should address the
physiological relationship between calcium channel inactivation
and ASD.
Kir4.1 and BKCa
Recent studies have linked potassium channel proteins Kir4.1
and BKCa to ASD. Mutational screens identiﬁed several missense
mutations in theKCNJ10 region encoding the potassium ion chan-
nel Kir4.1. This ATP sensitive inward rectiﬁer type potassium
channel is characterized by having a greater tendency to allow
potassium ions to ﬂow into the cell and is suggested to be respon-
sible for the buffering action of glial cells in the brain. Individuals
who possess a mutation in the region show symptoms consis-
tent with the DSM-IV-TR criteria for ASD along with seizure
and intellectual disability (Sicca et al., 2011). BKCa is a potas-
sium channel known for its large conductance of potassium ions
across cell membranes. The gene KCNMA1 encodes BKCa. which
is thought to function as a synaptic regulator of neuronal excitabil-
ity which seems to be disrupted in patients withASD (Laumonnier
et al., 2006). Disruption of this gene caused a decrease in BKCa
channel activity and haploinsufﬁciency in Autism patients further
implicating excessive ion channel activity to ASD (Ji et al., 2009).
SCAFFOLDING PROTEINS
Scaffolding proteins are essential molecules of the synaptic archi-
tecture. They are enriched in post-synaptic densities (PSDs)
and function in synapse biogenesis by trafﬁcking and anchoring
synaptic proteins and clustering of membrane-associated proteins.
Most importantly, the scaffolding proteins serve to link post-
synaptic receptors with their downstream signaling components
and regulate cytoskeletal dynamics (Verpelli et al., 2012).
Shank
Shank protein family is one such synaptic scaffolding fam-
ily of proteins that includes Shank1, Shank2, and Shank3.
They have multiple protein–protein interaction domains and
are also known as proline-rich synapse-associated proteins
(ProSAPs). Shank proteins are enriched in PSDs and stabi-
lize the PSD-95/SAPAP/Shank/Homer complex (Tu et al., 1999;
Sala et al., 2001). Additionally, Shank interacts with NMDA
receptors/PSD-95/GKAP complex and actin regulatory protein,
Cortactin (Naisbitt et al., 1999; refer Figure 1). Strong genetic
and molecular evidence has linked SHANK2 and SHANK3 to the
development of ASD phenotypes.
SHANK2
Mutations in ProSAP1/Shank2 gene result in an upregulation of
glutamate receptors in certain brain regions, an increase in Shank3
at the synapse, and a decrease in dendritic spine morphology and
synaptic transmission (Schmeisser et al., 2012). ProSAP/Shank2
mutants also display behavioral phenotypes that are consistent
with those seen in ASD. Shank2 mutant mice are hyperactive,
exhibit repetitive grooming, and have impairments in social and
vocal behaviors (Schmeisser et al., 2012). Such phenotypic man-
ifestations are linked to the reduction of NMDAR function that
results from the absence of the Shank2 protein (Won et al., 2012).
Human studies using microarray analyses have identiﬁed several
variants in SHANK2 that are associated with ASD and mental
retardation (Berkel et al., 2010).
SHANK3
Shank3 is an important member of Shank family of proteins
and interacts with NLGN (Gerrow et al., 2006) to play a key
role in spine morphogenesis and synaptic plasticity (Sala et al.,
2001). Recent studies on Shank3 using knockout mice suggest
its involvement in the regulation of glutamatergic synapse size,
shape, and structure (Jiang and Ehlers, 2013). In Shank3 knock-
out mice, synaptic ultrastructure is compromised. Overall, shank3
loss leads to a reduction in spine volume, decreased PSD thick-
ness, and loss of dendritic spines (Bozdagi et al., 2010; Peca et al.,
2011a; Wang et al., 2011; Jiang and Ehlers, 2013). Furthermore,
Shank3 knockout mice show abnormal social behaviors, com-
munication patterns, repetitive behaviors, and impairments in
learning and memory (Bozdagi et al., 2010; Peca et al., 2011a;
Wang et al., 2011).
There is growing evidence of the involvement of Shank3 in
ASD.Molecular characterization of individuals with 22q13.3 dele-
tion syndrome that display autism behavior identiﬁed a deletion
disrupting Shank3 among other genes (Wilson et al., 2003). Hap-
loinsufﬁciency of Shank3 has been conﬁrmed to account for 22q13
deletion phenotype of developmental and speech delays (Durand
et al., 2007). Other studies that attributed a role of Shank3 in
ASD include identiﬁcation of de novo splice site mutation in ASD
(Gauthier et al., 2009). More recently, Shank3 mutations iden-
tiﬁed in patients with ASD show a modiﬁcation in dendritic
spine induction and morphology as well as actin accumulation
in spines affecting growth cone motility (Durand et al., 2007).
Furthermore, a microdeletion in Shank1 locus has been discov-
ered using microarray analysis in individuals with ASD (Sato
et al., 2012). Recent studies have further uncovered the func-
tional role of Shank3 as Shank3 duplication in mice leads to
hyperactivity and spontaneous seizures much like human sub-
jects who have small duplications in the SHANK3 locus. These
recent studies further underscore the function of Shank3 in neu-
ronal function and possibly in the maintenance of a balance
between the excitatory and inhibitory (E/I) synaptic mechanisms
(Han et al., 2013).
SynGAP1
SynGAP1 encodes the RAS GTPase-activating protein (GAPs)
which is a critical component of the PSD. At the PSD, SynGAP1
regulates synapse development andmaintenance of proper synap-
tic function. It is known to interact with PSD-95 and colocalizes
with excitatory NMDA receptor complexes (Chen et al., 1998).
SynGAP is shown to play a critical role in the PSD during early
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postnatal development as SYNGAP1 knockoutmice for die during
early development (Kim et al., 2003). Furthermore,mice heterozy-
gous for SynGAP1 show impairments in learning and memory
consistent with its involvement in NMDA receptor complexes
(Komiyama et al., 2002). In humans, sequencing of the SYNGAP1
locus revealed mutations linked to non-syndromic mental retar-
dation evidencing the importance of SynGAP in synaptic plasticity
and learning (Hamdan et al., 2009). SynGap1 was recently impli-
cated ASD because many of its key interacting partners including
PSD-95/DLG4, SAP-102/DLG3, PSD-93/DLG2, Neurexins, and
Neuroligins have previously been associated with ASD (van de
Lagemaat and Grant, 2010). Recent evidence suggests that Syn-
GAP may play a crucial role in controlling the E/I balance in
cortical neurons through the regulation on ERK signaling path-
ways (Wang et al., 2013). This is interesting because the E/I balance
seems to be altered in individuals with ASD (Eichler and Meier,
2008; Won et al., 2013). Further characterization of SynGAP as a
regulator of synaptic function will provide additional insight into
its involvement in ASD.
CYTOSKELETAL PROTEINS
A set of cytoskeletal proteins is also mutated in individuals with
ASD. These include factors regulating dynamics of actin cytoskele-
ton, such as GAPs and guanosine exchange factors (GEFs; Newey
et al., 2005). Rare non-synonymous variants in cAMP-GEFII are
among candidate genes for autism in chromosome 2q (Bacchelli
et al., 2003). Mutations in tumor suppressor genes TSC1 and
TSC2 are also linked to ASD as the mutant proteins are thought
to perturb cytoskeletal dynamics and dendritic spine structure
in mutant animals (Folstein and Rosen-Sheidley, 2001). More
recently, microtubule associated protein, KATNAL2, has emerged
as a credible risk factor for ASD (Neale et al., 2012).
Apart from CAMs, scaffolding and cytoskeletal proteins, a
host of other receptors, transporters and channel proteins are
known to contribute toward the etiology of ASD (summarized
in Table 4). Discovery of more and more genes and genetic path-
ways are expanding the genetic landscape of ASD. It is interesting
to note that these genes include chromatin modiﬁers, DNA bind-
ing proteins, ion channels, and neurotransmitter receptors (State
and Sestan, 2012). Recently, CNVs in new candidate genes within
GABAergic signaling and neural development pathways associ-
ated with ASD were identiﬁed using genome wide SNP array
(Griswold et al., 2012). These genes include an allosteric binder
of GABA receptor, DB1, the GABA receptor-associated protein,
GABARAPL1 and a post-synaptic GABA transporter, SLC6A11.
Other genes contributing to the genetics of ASD include glutamate
receptors, such as GRID1, GRIK2, and GRIK4, synaptic regula-
tors, such as SLC6A8 and SYN3, and transcription factors, such as
Engrailed 2 (EN2; Griswold et al., 2012).
SIGNALING PATHWAYS
Signaling pathways are a complex system of communication
within cells that function to organize cellular activities. Signaling
pathways and cascades have long been implicated in many disease
models. Understanding signaling pathways may play a central role
in developing pharmacological or other agents to better treat dis-
ease. Currently, disruptions in signaling pathways are being linked
to the development of ASD phenotypes. One such pathway con-
nected to ASD is the mammalian target of rapamycin (mTOR)
pathway.
mTOR PATHWAY
Mammalian target of rapamycin is a serine/threonine protein
kinase involved in the regulation of cell proliferation, cell growth,
cell survival, protein synthesis, and transcription. The mTOR sig-
naling cascade plays a very important role in synapse protein
synthesis and several studies have linked this pathway to ASD
(Hay and Sonenberg, 2004; Hoeffer and Klann, 2010). Many of
the signaling components of the mTOR cascade are located at
the synapses where they have been shown to regulate dendritic
spinemorphology and synaptogenesis (Kumar et al., 2005). Muta-
tions in the proteins known to inhibit mTOR signaling including
NF1, PTEN, TSC1, and TSC2 are all linked to neurological dis-
ease and autistic-like behavioral phenotypes (Williams and Hersh,
1998; Butler et al., 2005; Won et al., 2013). Furthermore, muta-
tions in the downstream targets of the mTOR signaling cascade
have been identiﬁed in patients with ASD. The mTOR signal-
ing cascade works by the phosphorylation of 4E-BP by mTOR.
This causes 4E-BP to dissociate from the eIF4E initiation factor
resulting in cap-dependent translation and elongation of mRNA
(Laplante and Sabatini, 2009;Wang and Doering, 2013). Genomic
sequence analyses of the eIF4E promoter region identiﬁed a SNP
in autism patients that enhanced the promoter activity of eIF4E
(Neves-Pereira et al., 2009). Additionally, 4E-BP knockout mice
as well as mice with an overexpression of eIF4E show autistic
like behaviors, enhanced translational of Neuroligins, and disrup-
tions in the E/I balance (Gkogkas et al., 2013; Won et al., 2013).
Analyses of monogenetic sources of ASD found that approxi-
mately 8–10% of all ASD are involved in regulation of the mTOR
pathway (Moldin et al., 2006; Kelleher and Bear, 2008; Hoeffer
and Klann, 2010). Of those, 1–2% of ASD cases result due to
a mutation in the gene encoding PTEN, an upstream member
of the mTOR pathway (Hoeffer and Klann, 2010). The other
upstream members, TSC1 and TSC2, form a heterodimer com-
plex. Mutations in the genes encoding this complex cause TSC
which is deﬁned clinically by the appearance and growth of
benign hamartomas throughout the body and brain (Smalley,
1998). TSC patients suffer from mental retardation and epilepsy.
Recent studies show that 25–50% of patients with TSC show
behaviors that are consistent with ASD behavioral phenotypes
(Hoeffer and Klann, 2010). Pharmacological manipulations to
identify therapeutic targets that may be enhancers and suppres-
sors of mTOR signaling cascades and mRNA translation are
currently being explored to combat some of the phenotypic
manifestations associated with ASD (Carson et al., 2012). Fur-
ther studies into the downstream and upstream targets of the
mTOR signaling cascade will provide additional insights into
the functional relationship between the mTOR pathway and
ASD.
CONCLUDING REMARKS
Current efforts to identify the constellation of genes that confer the
characteristic phenotypic manifestations within the autism spec-
trum have improved our understanding of this complex disorder.
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While modeling mutations in experimental animal model systems
will highlight the underlying disruptions in conserved signaling
pathways, the daunting task will still be to establish ASD-speciﬁc
phenotypes at themolecular, cellular and neural circuit levels. The
staggering number of genes already discovered in ASD holds the
promise to translate the knowledge into designing new therapeutic
interventions. The very interesting and equally challenging obser-
vation from the recent genetic studies has been a high degree of
overlap of risk factors for various neurodevelopmental disorders,
such as ASD, epilepsy, and schizophrenia. This pattern of overlap
provides the feasibility to address which genes and genetic path-
ways intersect and specify the spatio-temporal sequence of events
that occur within the developing human brain. The recent advent
of comprehensive maps of spatio-temporal gene expression in the
human brain (Kang et al., 2011) will greatly help toward provid-
ing a powerful developmentally informed approach to studying
disorders such as ASD.
Although concerted efforts from studies of human clinical
ASD populations and various ASD-related animal models have
provided a better understanding of the genetic, molecular, and
circuit level aberrations in ASD, several intriguing, yet signiﬁ-
cant questions still remain. For instance, how can the compound
effects of genetics, epigenetics, and environment be consolidated
in understanding ASD pathogenesis? What other events play a
role in determining the appearance and trajectory of ASD symp-
toms? How do the majority of the genetic susceptibility loci in
ASD affect synapse assembly, maintenance and functional modu-
lation? Finally, howwould the future treatments and interventions
be designed and organized to accommodate the ever-changing
genetic landscape of ASD?
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